Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
Dofferhoff
A S
AS
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Bom
V J
VJ
van Ingen
J
J
de Vries-Hospers
H G
HG
Hazenberg
B P
BP
van der Meer
J
J
Mulder
P O
PO
Weits
J
J
D000209:Acute-Phase Proteins / Q000032:analysis*; D002444:Cefuroxime / Q000627:therapeutic use*; D015377:Cilastatin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004731:Endotoxins / Q000097:blood*; D005260:Female; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D014031:Tobramycin / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
D000209:Acute-Phase Proteins; D004731:Endotoxins; D007375:Interleukin-1; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D015377:Cilastatin; D015378:Imipenem; D002444:Cefuroxime; D014031:Tobramycin